QuartzBio paid ads audit: a disciplined audience split that already scores high and could score higher
QuartzBio sells Biomarker Intelligence and Sample Intelligence software into pharma and biotech R&D. Its paid ads make a useful case study because the account does something most B2B SaaS portfolios do not: split LinkedIn spend across five dedicated audience pages (pharma vs biotech, data-IT vs translational vs operations) and tune the copy to each. The audit is essentially a test of how cleanly that audience split holds up after the click.
Snapshot
- Total ads found
- 37
- Landing-page ads
- 37
- Channels
- Destinations matched
- 5
- Average score
- 8.4
How this account runs paid ads
QuartzBio spreads 37 LinkedIn landing-page ads across five audience-specific destinations. Each destination corresponds to one named persona: biotech data and IT teams, pharma data and IT teams, biotech translational teams, pharma translational teams, and lean sample-operations teams. The ad and the page agree on the persona; the page heroes mostly hold the scent.
Two product lines anchor the account: Biomarker Intelligence (four destinations) and Sample Intelligence (one destination). Both rely on the same handful of proof points (90 percent less data wrangling, 10x faster time to analysis, an 85 percent manual-work reduction in sample operations, top-pharma social proof) and the same low-friction conversion offer: a free 15-minute workflow review.
Because the audience split is so disciplined, this audit reads more like a finishing pass than a list of structural fixes. Every page is at least a B+. The lifts come from echoing the exact ad headline phrase in the H1, surfacing the strongest stat above the fold, and tightening the hero CTA to match a cold LinkedIn ad click.
Page report card
Hero already pays off the 90 percent data-wrangling promise and the 15-minute review; small lift from naming Biomarker Intelligence in the H1.
Strong end-to-end match; the unification claim and 10x stat both deserve a hero-level spot instead of living under the video.
Confident go/no-go promise matches the ad cluster; two near-fold CTAs are diluting a single click intent.
Pain story and 85 percent proof point match the ad, but the hero pivots to a different metaphor than the ad's exact category phrase.
Same unification story as the data-IT pharma page; the 15-minute review is too aggressive a primary CTA for a cold ad click.
This table only shows pages with a reviewed ad sample and a published score.
Common patterns
// Pattern 01
Audience-specific pages are doing the heavy lifting
Every page in this account is built for one named persona, and the ad copy aimed at that persona uses the same nouns. That alone explains why every score lands in the B+ band. Most accounts do not earn the option to do finishing-pass tweaks; this one does.
// Pattern 02
Hero H1s lead with outcomes; ads lead with the product name
Almost every page hero opens with the outcome (cut wrangling 90 percent, make confident go/no-go decisions, stop paying the spreadsheet tax). The ads usually open with the product name (Biomarker Intelligence, Sample Intelligence). A two-line H1 that combines both would close the last bit of headline-match gap on most pages.
// Pattern 03
Proof points live one section too low
10x time to analysis, 85 percent manual-work reduction, top pharmas, named case studies: these all appear on the pages, but typically under the hero in a video card or quote block. Moving them to a hero subhead bullet would let the click pay off without scrolling.
// Pattern 04
Primary CTA is consistently the 15-minute workflow review
This is a strong, low-friction offer and a smart bet for an account that runs almost entirely on LinkedIn. The remaining lift is wording: replacing generic Show me how or Schedule My Review labels with action verbs that name the review's value (Get my 15-minute sample bottleneck review, See how unification works) keeps scent through the click.
Should you copy this playbook?
Yes, with one caveat. QuartzBio is doing the unglamorous work most B2B SaaS accounts skip: build one landing page per persona, not a Frankenstein product page that tries to be all things to everyone. That decision alone is the reason every score in this audit is B+ or higher. The cost is real (five pages to maintain instead of one) but the message-match ceiling it unlocks is structural.
The caveat: do not stop at the URL split. The remaining message-match work in this account is finishing-pass copy at the hero. The H1, the first stat bullet, and the primary CTA together do most of the scent work. QuartzBio has already done the hard half; the easy half is shipping a one-line hero rewrite per page.
The biggest takeaway is that a disciplined audience split makes everything downstream easier. With one page per persona, every ad headline has somewhere honest to land, every proof point has room to surface, and every CTA can be tuned to the exact intent the ad sold. Accounts that do not do this work will always lose to accounts that do.
Sources
- LinkedIn Ad Library: Public ad data captured 2026-06-22
- Landing pages: quartz.bio captures from 2026-06-22
Want the same teardown for your account?
Get a free post-click audit that grades every active ad against the page it lands on and flags the top fixes by priority.
Audit my full account